Lacto-N-neohexaose(36824-93-8)
- Name: Lacto-N-neohexaose
- Synonyms:Lacto-N-neohexaose
- Molecular Formula:C40H68 N2 O31
- Molecular Weight:0
- CAS Registry Number:36824-93-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.36824-93-8 Lacto-N-neohexaose
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.36824-93-8 Lacto-N-neohexaose
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.36824-93-8 Lacto-N-neohexaose
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Lacto-N-neohexaose
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.36824-93-8 Lacto-N-neohexaose
Assay:97% Appearance:powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 285127-26-6/2(1H)-Pyridinethione, 1-[(fluorodimethylsilyl)methyl]-6-methyl-
- 285127-22-2/2(1H)-Pyridinethione, 1-[(chlorodimethylsilyl)methyl]-6-methyl-
- 3785-01-1/DASPEI
- 36844-51-6/4-Allyloxybenzoyl chloride
- 36841-50-6/[2-(4-NITRO-PHENYL)-OXAZOL-4-YL]-METHANOL
- 36841-47-1/(2-P-TOLYL-OXAZOL-4-YL)-METHANOL
- 285125-09-9/Pyridine, 4-isothiocyanato-3-methyl- (9CI)
- 36841-46-0/2-(4-NITRO-PHENYL)-OXAZOL-4-YLMETHYLAMINE HCL
- 36839-10-8/5-Isoxazolidinecarboxylicacid,ethylester(9CI)
- 36838-71-8/4-Methylenetetrahydro-2H-pyran
- 36838-64-9/2-Oxazolidinone,5-methyl-5-(phenylmethyl)-(9CI)
- 285124-33-6/Carbamic acid, [(1R)-1-(2-hydroxyethyl)-2-methylpropyl]-, 1,1-dimethylethyl
- 36833-53-1/Ethyl, 1-[(ethoxycarbonyl)oxy]- (9CI)
- 36830-74-7/BIS(2,2,6,6-TETRAMETHYL-3,5-HEPTANEDIONATO)STRONTIUM(II)
- 36827-98-2/1-(4-FLUORO-PHENYL)-2-PYRIMIDIN-4-YL-ETHANONE
- 36827-95-9/1-(4-METHOXYPHENYL)-2-PYRIMIDIN-4-YLETHANONE
- 36825-35-1/4-AMINO-2-BROMOQUINOLINE
- 36825-34-0/4-Bromo-3-quinolinamine
- 36825-32-8/2-AMINO-4-BROMOQUINOLINE
- 36824-93-8/Lacto-N-neohexaose
- 36821-26-8/2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID ETHYL ESTER
- 285124-27-8/Oxazolidine, 2-(1-methylethyl)-4-(2-methylpropyl)-, (4S)- (9CI)
- 36817-58-0/1-(3-ETHOXYPHENYL)-1H-PYRROLE-2,5-DIONE
- 36817-02-4/Thiocyanic acid, 2-(aminocarbonyl)phenylthiomethyl ester
- 284690-33-1/HUMAN LEUKOCYTE IFN
- 284673-31-0/5,12-Dimethyl-2,9-bis-trifluoromethyl-5,12-dihydroquino2,3-bacridine-7,14-dione
- 284673-30-9/2,9-Difluoro-5,12-dimethyl-5,12-dihydroquino2,3-bacridine-7,14-dione
- 284673-06-9/Benzoic acid, 3-amino-4-[(1-methylethyl)amino]- (9CI)
- 284672-95-3/4-(ISOPROPYLAMINO)-3-NITROBENZOIC ACID
- 284672-81-7/Benzoic acid, 3-amino-4-[(2-methoxyethyl)amino]- (9CI)